Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Solicitation opportunity from Government of Canada was posted on July 2, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Ultra high-performance liquid chromatography system with diode array and fluorescence detection

Closed
1000272585International

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The Health Canada Products Laboratory is seeking to procure a new ultra high-performance liquid chromatography system with diode array and fluorescence detection (UHPLC-DAD-FLD) through a solicitation reserved exclusively for suppliers pre-qualified under Supply Arrangement E60PV-19EQUI for laboratory and scientific equipment. Only vendors currently holding this supply arrangement are eligible to respond, and any submissions from non-qualified suppliers will be rejected without evaluation. The core requirement is the UHPLC-DAD-FLD system, with two optional additions: a second fluorescence detector and an extended warranty for the instrument. The award will be made to the responsive bidder offering the lowest aggregate price who meets all mandatory technical criteria. The place of performance is Canada, and the solicitation, numbered 1000272585, was posted on June 12, 2026, with a response deadline of July 2, 2026. The NAICS code for this procurement is 334516, and all correspondence should be directed to Eryn Mathers at eryn.mathers@hc-sc.gc.ca. Suppliers not yet qualified on the supply arrangement may access solicitation document E60PV-19EQUI/D through CanadaBuys (SAP Ariba) to apply for pre-qualification, but submissions for this specific procurement are limited to existing holders. No details on pricing, delivery timelines, packaging, inspection, or warranty terms beyond the optional extended coverage are provided in the available documentation.

General Info

Health Canada seeks UHPLC-DAD-FLD system with optional detector and warranty, responses due July 2, 2026.

Agency

Government of Canada → Department of HealthView Agency

NAICS

334516 - Analytical Laboratory Instrument ManufacturingView NAICS

Place of Performance

*Canada, CAN

Set-Aside

NONE

Documents

(2)

Invitation to Pre-Qualified Suppliers for UHPLC System - Solicitation 1000272585

PDFrfp

Solicitation 1000272585 for UHPLC System with Detection Options

PDFrfp

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyGovernment of Canada → Department of Health
Contacts1 person available
OfficeN/A
Organization / Agency
Government of Canada → Department of Health
View Agency Profile
Office AddressN/A
Contacts
Eryn MathersPoint of Contact

Full Description

Show more
The Health Canada Products Laboratory requires the purchase of a new ultra high-performance liquid chromatography system with diode array and fluorescence detection (UHPLC-DAD-FLD), with a option to purchase a second fluorescence detector and/or an extended warranty for the instrument.

More opportunities from Government of Canada → Department of Health

Same awarding agency

NAICS: 541715
International
Request For Proposal (RFP) for Pharmacological testing of novel opioids, stimulants, and synthetic cannabinoids.
Solicitation # 1000273405
Health Canada is seeking proposals under solicitation 1000273405 to conduct in vitro pharmacological testing of novel psychoactive substances to support regulatory science and risk assessments regarding the illegal drug supply. The procurement is divided into three separate streams: Stream 1 focuses on emerging opioids at the Mu Opioid Receptor, Stream 2 addresses novel synthetic cannabinoids targeting CB1 and CB2 receptors, and Stream 3 evaluates stimulant compounds, specifically dopamine and VMAT2 uptake. Bidders may submit proposals for a single stream, two streams, or all three, with the possibility of up to three contracts being awarded. The selected contractors will be responsible for acquiring reference standards and control samples, obtaining necessary licenses for controlled substances, and performing rigorous laboratory experiments including assay validation and pharmacodynamic testing. Key deliverables include the measurement of metrics such as Ki, Emax, and EC50, followed by statistical analysis and the submission of draft and final reports. Timelines for completion vary by stream, with some activities extending up to 17.5 months from the date of the contract award. Technical and financial offers must be submitted separately for each stream by the deadline of September 18, 2026.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

11 days ago

DEADLINE

in 7 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS